Group Action Lawyers
Latest News & Updates

March 21, 2018
Are 3D printed medical devices and implants the way forward?

Medical devices and implants have come on leaps and bounds in recent years, but we often see a lot of compensation claims arising out from them as well. One issue with medical devices and implants is that they can be difficult to customise to different patients, but the issue could potentially be resolved with new 3D printing technology.

It’s early days, but 3D printed medical devices and implants are being used to help patients.

Is this new technology they the way forward to seeing a better world of safer implants and devices that can be made quickly and effectively?
Continue Reading…

new research into exploding e-cigs
March 19, 2018
Is there a link between E-cigarette design and dangers from e-cig battery explosions?

The E-cigarette revolution continues to spread, but as the products have become more popular and are now attracting plenty of players in the market, we have seen incidents and research that has questioned their effectiveness as well as their safety.

A hot topic right now is the stories about e-cig explosions. We have seen incidents around the world where victims have been left with serious burns after their e-cig batteries exploded, with some left with serious burns and permanent damage to the facial area.

Now, some experts believe there is a direct link between the design of the e-cigarette and the potential for damage from explosions.
Continue Reading…

experts warn of buying diet pills online
March 16, 2018
Consumers warned about buying diet pills online

The internet has opened up a wealth of opportunities for consumers to find new suppliers in all market sectors, but one of the more popular ones is the health and beauty market. The option for shopping for diet products with discretion is often a bonus for consumers, but with the growth of platforms like Amazon and eBay, there are new warnings about purchasing diet pills online.

Some experts have warned against people putting their faith in buying diet pills online, and regulators have already stepped in over the kinds of claims the suppliers and manufacturers are making.
Continue Reading…

apple battery controversy
March 14, 2018
We now know Apple are slowing down batteries to “prolong lifespan” and “prevent sudden shutdown” – but, is this acceptable?

When Apple admitted that their updated software is slowing down older models, many were outraged. The frequency of new models being released is far too much for some; especially when the cost of a new model can easily set you back a lot of money and equate to more than £100 a month.

For a phone!

So, is Apple’s explanation that they introduced the feature for the iPhone 6 and later models to protect problems occurring with batteries acceptable?
Continue Reading…

hormonal contraceptive cancer study
March 12, 2018
All hormonal contraception like ‘the pill’ can still increase breast cancer risks

It has been reportedly known for a while that forms of hormonal contraception like ‘the pill’ have been linked with increased risks of women developing breast cancer. However, despite hopes of improvements, a new study involving millions of women over a period of years has reaffirmed the apparent risks associated with contraception and cancer.

Studies have found that the increased risks of breast cancer can remain until five years after hormonal contraception has been stopped as well.
Continue Reading…

thousands of cervical screening tests to be re-screened
March 09, 2018
Lab error leads to thousands of cervical screening tests being reviewed

A laboratory run by Pathology First, working on behalf of Basildon and Thurrock NHS Foundation Trust, are having to redo thousands of cervical screening tests for cancer after an error was discovered.

The samples affected, which were taken between April 2016 and September 2017 for women aged between 24 and 29 who had smear tests, as well as a number of women in their 60’s, are being re-screened independently.

The results held by the lab were classed as negative, but having had some 2,500 samples re-screened, 17 women have reportedly been invited for further assessments.
Continue Reading…

medical safety
March 07, 2018
Aquilon nebulisers – CE mark withdrawn and supply ceased, but many have remained on the market

Despite withdrawal of the CE safety marking for Aquilon series of nebulisers, manufactured by AFP Medical, the nebulisers have still been placed on the market. A number of devices may have been sold despite the withdrawal of the CE marking, which means the safety of the product cannot be guaranteed.

CE safety certification is vital for consumer and supplier confidence in a product, and when it comes to medical products, such approval – or withdrawal, as is the case here – can be even more important.
Continue Reading…

hernia mesh compensation claims
March 05, 2018
UK government investigating the scale of harm caused by vaginal mesh implants

Our legal team have been assisting people in various situations involving harm caused by vaginal mesh implants.

The UK government review update is welcome news.

Years after the UK’s Medicines & Healthcare products Regulatory Agency (MHRA) investigated issues and decided against recalls and bans, the National Institute for Health and Clinical Excellence (NICE) has suggested the surgery should be banned, and New Zealand have become the first country in the world to put an outright ban in place.
Continue Reading…

Mercedes emissions settlements
March 02, 2018
Will the UK follow in the footsteps of the US when it comes to group actions?

Group actions in the US – or “class actions” as they’re referred to across the pond – can consist of thousands or even millions of victims claiming for similar issues. In America, there are practically always class actions going on for all sorts of things, ranging from medical and product liability suits, to employee rights cases and data breach litigation.

Its massive over there. The question now is whether the UK is set to follow suit or not in operating in a similar way to the US.
Continue Reading…

pregnancy epilepsy drug concerns
February 28, 2018
Birth defects reportedly caused by in-utero exposure to Epilepsy Drug

A drug that helps control epileptic seizures has been reportedly linked to birth defects and should not be used by pregnant women or women of child-bearing potential.

Depakote was created by French pharmaceutical drug company Sanofi back in 1967. The British equivalent, Epilim, has been available since 1973.

The drug has been used around the world and has gained regulatory approval for treatment of epilepsy, with variations of the drug introduced in 1995 for bipolar manic episodes, and in 1996 to prevent migraines. But, a generation later, it has been revealed the drug can cause severe birth defects at a significantly high percentage.
Continue Reading…

emissions compensation claims
February 26, 2018
Fiat Chrysler Jeep explosion sees campaigners ask for fuel tank recall to be re-investigated

In August 2017, a woman was killed when her Jeep SUV’s fuel tank combusted after she was rear-ended. The incident has raised further concerns that the 2013 recall over the Jeep’s fuel tank was not enough to protect motorists.

The victim’s 2007 Jeep was one of the 1.56 million sport utility vehicles that Fiat Chrysler agreed to install trailer hitches on to protect the fuel tanks. More than five years ago, Chrysler Group recalled 2.7 million sport-utility cars after the vulnerability was linked to the deaths of 51 people after crashes ignited fuel.
Continue Reading…

pharmatech liquid drugs contaminated
February 23, 2018
PharmaTech LLC packs up manufacturing plant after its liquid drugs are found to be contaminated with B.Cepacia bacteria

All of PharmaTech LLC’s liquid drugs made at one manufacturing plant have been recalled, with regulators advising consumers not to use them.

Reportedly, the drugs have been contaminated with Burkholderia cepacia bacteria.

Patient infections have been linked to the drugs, meaning regulators are warning against the use of their products. Notably, this is not PharmaTech’s first brush with the law. Regulators have been involved with them three times in less than a year for similar issues involving the bacteria.
Continue Reading…